Drugmakers ready response as regulator targets brand name extensions
The DCGI has warned pharma associations of strict action against the practice of extending a primary brand name to treat a completely different illness.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)